Suppr超能文献

铁死亡抑制剂通过下调转化生长因子-β1减轻放射性肺纤维化(RILF)。

Ferroptosis inhibitor alleviates Radiation-induced lung fibrosis (RILF) via down-regulation of TGF-β1.

作者信息

Li Xuan, Duan Lijie, Yuan Sujuan, Zhuang Xibing, Qiao Tiankui, He Jian

机构信息

1Department of Radiation Oncology, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032 China.

2Department of Radiation Oncology, Jinshan Hospital, Fudan University, 1508 Longhang Road, Shanghai, 201508 China.

出版信息

J Inflamm (Lond). 2019 May 29;16:11. doi: 10.1186/s12950-019-0216-0. eCollection 2019.

Abstract

BACKGROUND

Radiation-induced lung fibrosis (RILF) is a severe and life-threatening complication of thoracic radiotherapy. Cell death is the key issue in RILF. Ferroptosis is a form programmed cell death implicated in the pathologies of inflammation. This study aimed to investigate the role of ferroptosis in RILF, and the effectiveness and the potential underlying mechanism of ferroptosis inhibitor on RILF.

METHODS

Immunofluorescence, western blot and RT-PCR assays were performed to examine the ferroptosis maker glutathione peroxidase 4 (GPX4) in a mice RILF model. The lung tissue sections were stained with hematoxylin and eosin (H&E), Masson trichrome staining and Sirius-Red staining to evaluate the histopathological changes in RILF mice. Reactive oxygen species (ROS) and hydroxyproline (HYP) in lungs were measured by the relevant kits. The serum levels of inflammatory cytokines (TNF-α, IL-6, IL-10, and TGF-β1) were measured with Elisa. The protein and mRNA levels of GPX4, nuclear factor (erythroid-derived 2)-like 2 (Nrf2), hemeoxygenase-1 (HO1) and quinone oxidoreductase 1 (NQO1) in lungs were examined by western blot and RT-PCR.

RESULTS

GPX4 levels of the irradiated lungs were significantly down-regulated than the groups with no irradiation, and the ferroptosis inhibitor, liproxstatin-1, increased GPX4 levels significantly in RILF mice. Treatment with liproxstatin-1 lowered the Szapiel and Ashcroft scores significantly, down-regulated the levels of ROS and HYP in lungs and reduced the serum inflammatory cytokines levels in RILF mice. The protein and the mRNA levels of Nrf2, HO1 and NQO1 were up-regulated by liproxsratin-1 in RILF.

CONCLUSIONS

Our data suggested that ferroptosis played a critical role in RILF, ferroptosis inhibitor liproxstatin-1 alleviated RILF via down-regulation of TGF-β1 by the activation of Nrf2 pathway. The effectiveness of ferroptosis inhibition on RILF provides a novel therapeutic target for RILF.

摘要

背景

放射性肺纤维化(RILF)是胸部放疗的一种严重且危及生命的并发症。细胞死亡是RILF的关键问题。铁死亡是一种程序性细胞死亡形式,与炎症病理过程有关。本研究旨在探讨铁死亡在RILF中的作用,以及铁死亡抑制剂对RILF的有效性和潜在作用机制。

方法

采用免疫荧光、蛋白质印迹和逆转录-聚合酶链反应(RT-PCR)检测小鼠RILF模型中铁死亡标志物谷胱甘肽过氧化物酶4(GPX4)。用苏木精-伊红(H&E)染色、Masson三色染色和天狼星红染色对肺组织切片进行染色,以评估RILF小鼠的组织病理学变化。用相关试剂盒检测肺组织中的活性氧(ROS)和羟脯氨酸(HYP)水平。用酶联免疫吸附测定法(ELISA)检测血清中炎症细胞因子(肿瘤坏死因子-α、白细胞介素-6、白细胞介素-10和转化生长因子-β1)水平。通过蛋白质印迹和RT-PCR检测肺组织中GPX4、核因子(红系衍生2)样2(Nrf2)、血红素加氧酶-1(HO1)和醌氧化还原酶1(NQO1)的蛋白质和mRNA水平。

结果

与未照射组相比,照射后肺组织中GPX4水平显著下调,铁死亡抑制剂liproxstatin-1可显著提高RILF小鼠肺组织中GPX4水平。liproxstatin-1治疗可显著降低RILF小鼠的Szapiel和Ashcroft评分,下调肺组织中ROS和HYP水平,并降低血清炎症细胞因子水平。liproxstatin-1可上调RILF小鼠肺组织中Nrf2、HO1和NQO1的蛋白质和mRNA水平。

结论

我们的数据表明,铁死亡在RILF中起关键作用,铁死亡抑制剂liproxstatin-1通过激活Nrf2途径下调转化生长因子-β1来减轻RILF。抑制铁死亡对RILF的有效性为RILF提供了一个新的治疗靶点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验